11 – 20 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
(
- Contribution to journal › Article
- 2021
-
Mark
ARTSCAN III : A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer
(
- Contribution to journal › Article
-
Mark
Low-Dose Tamoxifen for Mammographic Density Reduction : A Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Burkitt Lymphoma International Prognostic Index
2021) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39(10). p.1129-1138(
- Contribution to journal › Article
-
Mark
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer : Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
2021) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39(20). p.2294-2303(
- Contribution to journal › Article
- 2020
-
Mark
Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).
(
- Contribution to journal › Published meeting abstract
-
Mark
Cancer risks associated with germline PALB2 pathogenic variants : An international study of 524 families
(
- Contribution to journal › Article
-
Mark
Comment on "factors affecting sentinel node metastasis in thin (T1) cutaneous melanomas : Development and external validation of a predictive nomogram"
(
- Contribution to journal › Letter
- 2019
-
Mark
Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma : A Nordic Lymphoma Epidemiology Group Study
(
- Contribution to journal › Article
-
Mark
Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia : A Pooled Analysis of Individual Patient Data From Nine International Cohorts
(
- Contribution to journal › Article